We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.80 | 8.24% | 36.80 | 36.60 | 37.30 | 37.30 | 35.00 | 35.00 | 753,383 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.81 | 109.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2024 08:49 | "I take this as an assumption" How can it be an assumption? (Are you suggesting they might be misguiding?) | glavey | |
09/2/2024 08:49 | Yes it is a ‘clinically proven’ fact. Other Hydroalcoholc gels have placebo effects in ED just like Eroxon. Especially when the clinical studies are manipulated to exclude men with any any underlying organic ED and include men with psychological ED. ˜the positive effect of the placebo in this clinical trial is all the less surprising given that the most affected patients were excluded, in particular those for whom the erectile problems could be explained by another pathology’ Men were first treated with tadalafil 10 mg once a day (OAD) for 4 weeks; if not successful, they were randomized in a double-blind, placebo-controlled design to receive placebo or a 1% hydroalcoholic T gel (50 mg/5 g gel) Erectile function progressively improved over a period of at least 12 weeks in both the placebo and T treatment groups. Researchers found that, over 14 weeks, men who were randomly assigned to take Viagra plus testosterone gel did no better than those given the drug plus a hormone-free placebo gel. Overall, men in both groups responded to the drug, Spitzer said. On average, the men's score on a standard set of erectile dysfunction questions increased by about 8 points “moving them up to the "mild" erectile dysfunction category. And there was no substantial difference between men who used the testosterone gel and those who used the placebo. | mdi | |
09/2/2024 08:44 | MDI - you do not know what you are saying is true which is stated as fact. Total idle speculation. The only gel that is approved by reulatory authorities is ours. We need to see far more data to fully understand what groups of patients find most benefit and this will build up as we get feedback from repeat buyers who become dependent on this as a longer term option. | takeiteasy | |
09/2/2024 08:35 | I take this as an assumption - but I can see that there are statistics for the UK sales of prescription drugs for ED via GP surgeries. This does not include I suspect amazon sales - but one for the board to confirm. | takeiteasy | |
09/2/2024 08:32 | "We have a 20% market share" But 20% share of what exactly? | glavey | |
08/2/2024 19:39 | Looks like I was right a few days ago - 31/1/2024 10:43 Looks like FUM is in for another big rise if the stock bashers are posting frantically again! Always the same whatever name LiarBO/LBO/MDI posts under. He's still doing it now so more rises on the cards, I believe! | petroc | |
08/2/2024 18:57 | MDI ie Mentally Deficient Idiot, why don’t use FUM erection gel on your head to erect some of your brain dead cells? To have to spend all day every day on a share your not invested in, must be a very sad life you must lead. No one to give a hug you crave for, which is probably the reason why you aren’t in need of Fum gel lol. | comek | |
08/2/2024 18:15 | Even David Ralph confirms the ‘single fact’ the YouTube video which is affiliate linking Eroxon is factually incorrect and misleading men claiming Eroxon has proven effect against a placebo gel. Eroxon was the placebo in FM57. Article translated: Its virtues against erection problems are just like placebo. Le Point contacted David Ralph, professor of urology at University College London and co-author of said clinical trial. We tested the glyceryl trinitate gel against a placebo The latter ultimately proved to be as effective and without clinical effect, hence its marketing without a prescription under the name Eroxon Stimgel, he replied to us. In other words, the laboratory therefore decided to put on sale the placebo based on water and glycerin used in its test instead of the product tested! | mdi | |
08/2/2024 17:11 | You are clearly in a mental state where there is not a single fact about this product and company you accept as truth. You ought to declare that you are being paid for articulating this though so others can understand better why you take such a position. The firm has answers to every single point you raise. A polite request though when you have your cereal tomorrow just spare the board just one day with not going through the placebo point with the same cut and pastes. I assume you make a note of which cut and pastes you apply each day - are you up to 50 or 100 times yet on the repeat button... | takeiteasy | |
08/2/2024 16:29 | I think the firm has removed over 580 scamming websites around the globe, with non medically trained individuals with a poor grasp of medical principles trying to make sense of their products and failing badly. It is just a shame you cannot seem to work this all out... | takeiteasy | |
08/2/2024 16:20 | A soft launch in H1 that got softer in H2? And without the misinterpretation and factually incorrect youtube video about FM57 and that video affiliate linking Eroxon. What would sales have been? Even softer? And lets not forget Eroxon won an award for spending the best big budget on marketing Eroxon. And since Eroxon only launched in April 2023 they managed to spend the over £0.5 million required in marketing in an even shorter period. Just between April 2023 - August 2023. BEST BIG BUDGET OTC MARKETING CAMPAIGN This Award is designed for big-budget OTC brands which have been supported by a total marketing spend – both above-the-line and below-the – line – exceeding £0.5 million between August 2022 – August 2023 WINNER Eroxon, Futura Medical Wellness Investors: Beware The Placebo Trap Whats the problem with placebos? Placebo effects tend to wear off, and when they do, your customers will drop off. This forces tremendous spending on acquisition since it can cost five times as much to acquire new customers than keep current ones. Since repeat customers generate more than half of the revenue for a majority of businesses, pretty packaging of a placebo will likely struggle to sustain sales. Perhaps the boom and bust commonly seen with wellness brands isn’t due to the hype cycle, but rather the placebo cycle. | mdi | |
08/2/2024 16:06 | Err MDI it was a soft launch - perhaps you might want to use chatGBT to work out what that means when querying the sales numbers... | takeiteasy | |
08/2/2024 15:47 | Yep 20% market share. Replicate that across the world | allstar4eva | |
08/2/2024 15:45 | MDI your paid deramping attempts are an absolute fail, Eroxon is out there now and selling, it will go on to sell more and more and more. You can't disprove the sales actuals. | mike2042 | |
08/2/2024 12:54 | Revenues of £3.1M equate to £1.4M for H2 compared to £1.7M in H1. Why couldn’t sales even be sustained never mind continuing to grow since its claiming to be ‘clinically proven’ and such a ‘breakthrough& Wellness Investors: Beware The Placebo Trap Whats the problem with placebos? Placebo effects tend to wear off, and when they do, your customers will drop off. This forces tremendous spending on acquisition since it can cost five times as much to acquire new customers than keep current ones. Since repeat customers generate more than half of the revenue for a majority of businesses, pretty packaging of a placebo will likely struggle to sustain sales. Perhaps the boom and bust commonly seen with wellness brands isn’t due to the hype cycle, but rather the placebo cycle. | mdi | |
08/2/2024 12:15 | #welovem&aOmg its all about to happen | j777j | |
08/2/2024 11:13 | I am waiting with interest what you have ready for us when we head above 40p - to try to hold back the tide :) | takeiteasy | |
08/2/2024 08:18 | Just like patent claims for a specific placebo hydroalcoholic gel formulation will most likely fail to stand up to well funded scrutiny if Eroxon is supposedly in a market worth millions and claiming to be taking a sustainable 20% of the total ‘clinically proven’ ED treatment market. All the information is based on freely available evidence all over the internet to anyone in the market who bothers to do some basic research. | mdi | |
08/2/2024 08:01 | I admire your efforts takeiteasy but he's a bitter broke nutjob and blames it all on Futura. You can't reason with insanity. | broomrigg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions